posted on 2017-04-19, 23:32authored byHilaria Esiawonam Kafui Abla Amuzu
Dengue fever is a
severely debilitating disease caused by the dengue virus (DENV) and transmitted
by Aedes aegypti mosquitoes. There is no specific treatment for the disease and
the current vaccine does not give complete protection against DENV. A novel
control approach involves the use of the maternally transmitted endosymbiotic
bacterium Wolbachia as a bio-control agent. Wolbachia is present in 40% of
insects but not Ae. aegypti. However Wolbachia has been artificially introduced
into Ae. aegypti where it forms stably inherited infections. Wolbachia is able
to manipulate female reproduction leading to inviable eggs when an infected
male mates with an uninfected female or females with a different strain of
Wolbachia. This characteristic, known as cytoplasmic incompatibility enables
Wolbachia infection to spread through wild populations. Wolbachia also has the
ability to limit the replication of co-infecting pathogens in mosquitoes.
Wolbachia infected mosquitoes are currently being released into the field to
trial whether they will interrupt DENV transmission to humans.
The mechanistic basis of Wolbachia-DENV blocking is not well
understood. There is evidence that Wolbachia activates the host’s immune
response thereby making it able to resist subsequent DENV infection in a
process known as ‘immune priming’. Competition between Wolbachia and the virus
for limited host resources has also been linked with Wolbachia-DENV blocking.
Immune priming and resource competition, however, do not fully explain
Wolbachia-DENV inhibition. The strength of blocking appears to correlate with
Wolbachia density, with highly infected mosquitoes and cell lines exhibiting
almost complete DENV inhibition.
This thesis therefore focussed on understanding the effect
Wolbachia density has on DENV blocking in various mosquito tissues by
increasing nutritional resources through feeding Ae. aegypti mosquitoes multiple
human blood meals. We found that multiple blood meals do not increase Wolbachia
density or DENV blocking, indicating that the Wolbachia-mediated DENV
inhibition should be stable throughout the lifespan of Ae. aegypti. This thesis
also investigated whether particular mosquito tissues were important for DENV
blocking by virtue of their Wolbachia density or functional roles in infection
and immunity. We found that no particular tissue type was important for
Wolbachia-DENV blocking, suggesting that the mechanisms underpinning blocking
should be systemic or fundamental to diverse cell types.
Mosquitoes are naturally infected with viruses, including
flaviruses known as insect-specific flaviviruses (ISF). Although ISF are
incapable of infecting vertebrates they may alter susceptibility of mosquitoes
to medically important flaviviruses. The effect Wolbachia has on ISF is
currently unknown. This thesis therefore examined whether the anti-virus effect
demonstrated for flaviviruses including DENV is observed for ISF. Surprisingly,
Wolbachia enhanced ISF infection rates and loads indicating that
Wolbachia-mediated anti-virus effect is not universal to all flaviviruses.
Further study is therefore required of Wolbachia-ISF interactions and the
effect this has on arboviruses such as DENV.
This thesis has clearly demonstrated that feeding mosquitoes
repeatedly on human blood does not influence Wolbachia-DENV inhibition and that
blocking is not dependent on a particular tissue type further adding to the
emerging understanding of Wolbachia-DENV interactions. In addition it has
demonstrated that the anti-virus effect of Wolbachia is not common to all
flaviviruses.